In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sepracor to co-promote MedPointe's Astelin in US

Executive Summary

Under terms of a multi-year agreement, Sepracor has licensed US co-promotion rights to MedPointe's (specialty pharmaceuticals and diagnostics) Astelin (azelastine) nasal spray antihistamine. Sepracor is responsible for its own marketing costs and gets a percentage of net sales above a mutually agreed upon baseline sales level.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Co-Promotion

Related Companies